SI2264050T1 - Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe - Google Patents

Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe

Info

Publication number
SI2264050T1
SI2264050T1 SI200231091T SI200231091T SI2264050T1 SI 2264050 T1 SI2264050 T1 SI 2264050T1 SI 200231091 T SI200231091 T SI 200231091T SI 200231091 T SI200231091 T SI 200231091T SI 2264050 T1 SI2264050 T1 SI 2264050T1
Authority
SI
Slovenia
Prior art keywords
porcine circovirus
dna clones
infectious dna
chimeric
relates
Prior art date
Application number
SI200231091T
Other languages
English (en)
Slovenian (sl)
Inventor
Xiang-Jin Meng
Martijn Fenaux
Patrick G. Halbur
Original Assignee
Virginia Tech Intellectual Properties, Inc.
Iowa State University Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties, Inc., Iowa State University Research Foundation, Inc. filed Critical Virginia Tech Intellectual Properties, Inc.
Publication of SI2264050T1 publication Critical patent/SI2264050T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200231091T 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe SI2264050T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34077501P 2001-12-12 2001-12-12
US42484002P 2002-11-08 2002-11-08
US10/314,512 US7276353B2 (en) 2001-12-12 2002-12-09 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
EP10184702.8A EP2264050B1 (en) 2001-12-12 2002-12-11 Chimeric infectious dna clones of porcine circovirus and uses thereof

Publications (1)

Publication Number Publication Date
SI2264050T1 true SI2264050T1 (sl) 2018-12-31

Family

ID=27405726

Family Applications (3)

Application Number Title Priority Date Filing Date
SI200230932T SI1487483T1 (sl) 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe
SI200231053T SI2263689T1 (sl) 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe
SI200231091T SI2264050T1 (sl) 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SI200230932T SI1487483T1 (sl) 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe
SI200231053T SI2263689T1 (sl) 2001-12-12 2002-12-11 Himerni infekciozni DNA kloni prašičjega cirkovirusa in njihove uporabe

Country Status (30)

Country Link
US (1) US7276353B2 (enExample)
EP (5) EP2264050B1 (enExample)
JP (1) JP4623964B2 (enExample)
KR (1) KR101014544B1 (enExample)
CN (2) CN103536911B (enExample)
AT (1) ATE487490T1 (enExample)
AU (3) AU2002362147C1 (enExample)
BE (1) BE2011C008I2 (enExample)
BR (1) BRPI0214919B1 (enExample)
CA (2) CA2469599C (enExample)
CO (1) CO5590938A2 (enExample)
CY (3) CY1111167T1 (enExample)
DE (2) DE122011100001I1 (enExample)
DK (3) DK2263689T3 (enExample)
ES (3) ES2355814T3 (enExample)
FR (1) FR11C0014I2 (enExample)
HR (3) HRP20040626B9 (enExample)
HU (5) HU231162B1 (enExample)
LT (1) LT2264050T (enExample)
LU (1) LU91814I2 (enExample)
ME (1) ME00126B (enExample)
MX (1) MXPA04005364A (enExample)
NL (1) NL300480I2 (enExample)
NZ (2) NZ533256A (enExample)
PL (3) PL395510A1 (enExample)
PT (3) PT1487483E (enExample)
RS (1) RS51288B (enExample)
SI (3) SI1487483T1 (enExample)
TW (1) TWI314580B (enExample)
WO (1) WO2003049703A2 (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) * 2004-08-18 2010-12-08 金宁一 共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
EP2460819A3 (en) 2004-12-30 2013-01-09 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) * 2005-04-07 2007-07-25 南京农业大学 猪ⅱ型圆环病毒重组腺病毒
MX2007016083A (es) * 2005-06-24 2008-03-10 Intervet Int Bv Vacunas quimericas inactivadas y metodos relacionados de uso.
UA95458C2 (ru) 2005-09-09 2011-08-10 Интервет Интернешонал Б.В. Вакцина против pcv-2 у mda-положительных поросят
MX356667B (es) 2005-12-29 2018-06-08 Boehringer Ingelheim Vetmedica Inc Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
BRPI0620859A2 (pt) * 2005-12-29 2011-11-22 Boehringer Ingelheim Vetmedica, Inc. vacina de combinação multivalente contra pcv2
JP4625485B2 (ja) * 2006-09-29 2011-02-02 財団法人大阪産業振興機構 高病原性トリインフルエンザウイルスに対するモノクローナル抗体
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (en) * 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
DK2094872T4 (da) * 2006-12-15 2020-05-18 Boehringer Ingelheim Animal Health Usa Inc Behandling af anti-PCV2-antistofseropositive svin med PCV2-antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
MX2009012793A (es) * 2007-05-30 2010-03-26 Wyeth Llc Poxvirus de mapache que expresa genes de virus porcino.
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
UA98812C2 (ru) * 2007-11-06 2012-06-25 Вайет Ллк Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
EP2225367A1 (en) * 2007-12-21 2010-09-08 Wyeth LLC Methods and compositions for immunizing pigs against porcine circovirus
AU2008347235A1 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 virus like particle with foreign amino acid insertion
WO2009126356A2 (en) * 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US20110033495A1 (en) * 2008-02-15 2011-02-10 Boehringer Ingelheim Vetmedica, Inc. Methods and compositions for reducing the impact of enteric diseases
NZ588639A (en) * 2008-04-16 2012-10-26 Virginia Tech Intell Prop CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
SI2547770T1 (sl) 2010-03-16 2020-07-31 Virginia Tech Intellectual Properties, Inc. Vakcina atenuiranega živega himernega prašičjega virusa
TWI442935B (zh) 2010-12-22 2014-07-01 Sbc Virbac Ltd 豬第二型環狀病毒（Ｐｏｒｃｉｎｅ Ｃｉｒｃｏｖｉｒｕｓ Ｔｙｐｅ ２）、含彼之免疫組合物、檢測套組及其應用
EP2660356A4 (en) 2010-12-28 2014-07-09 Jx Nippon Oil & Energy Corp DEVICE FOR HYDROGENATING ORGANIC COMPOUNDS AND HYDROGENATION METHODS
HUP1100470A2 (en) * 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
KR102217387B1 (ko) * 2013-03-11 2021-02-19 주식회사 중앙백신연구소 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
CA2925281C (en) 2013-09-25 2022-05-03 Zoetis Services Llc Pcv2b divergent vaccine composition and methods of use
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
CN103602759B (zh) * 2013-11-22 2015-09-23 福建省农业科学院畜牧兽医研究所 一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
BR112016012435A8 (pt) 2013-12-03 2018-01-30 Intervet Int Bv vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
EP3426293A4 (en) * 2016-03-07 2019-10-30 Virginia Tech Intellectual Properties, Inc. CHIMERIC VACCINES AGAINST PORCINE CIRCOVIRUS TYPE 2 (PCV2)
CN106497892A (zh) * 2016-09-07 2017-03-15 扬州大学 带KT3标签的重组病毒rPCV2‑KT3的构建方法
AU2019242601B2 (en) 2018-03-26 2025-12-04 Boehringer Ingelheim Animal Health USA Inc. Method of producing an immunogenic composition
CN112898435B (zh) * 2021-01-14 2023-03-31 山西农业大学 一种可溶性融合蛋白DT390-Cap及其制备方法与应用
AU2024265654A1 (en) 2023-05-03 2025-12-04 Boehringer Ingelheim Vetmedica Gmbh Method for inducing an immune response
WO2024228148A1 (en) 2023-05-03 2024-11-07 Boehringer Ingelheim Vetmedica Gmbh Immunogenic composition useful for self-administration by pigs
US20250332242A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2769321B1 (fr) 1997-10-03 2001-10-26 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2769322B1 (fr) 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1037909B1 (en) * 1997-12-11 2007-06-13 University of Saskatchewan Postweaning multisystemic wasting syndrome virus from pigs
AU770002B2 (en) 1998-03-13 2004-02-12 University Of Georgia Research Foundation, Inc., The Vaccines against circovirus infections
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
CA2413265A1 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
CA2409874A1 (en) 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
EP1290016A2 (en) 2000-06-15 2003-03-12 Purdue Research Foundation Vaccine for congenital tremors in pigs
DE10044648A1 (de) 2000-09-08 2002-03-21 Aventis Behring Gmbh Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
KR100876629B1 (ko) 2001-03-27 2009-01-07 유니버시티 오브 사스카췌완 써코바이러스의 배양 방법
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines

Also Published As

Publication number Publication date
NL300480I2 (enExample) 2016-11-01
PT1487483E (pt) 2011-02-10
HU230576B1 (hu) 2017-01-30
AU2002362147A1 (en) 2003-06-23
WO2003049703A3 (en) 2004-09-30
EP2263690A3 (en) 2011-06-08
HRP20140002A2 (hr) 2014-11-07
KR20040086243A (ko) 2004-10-08
EP2264050A2 (en) 2010-12-22
DE122011100001I1 (de) 2011-09-08
NZ567688A (en) 2009-09-25
HUS2100036I1 (hu) 2021-09-28
FR11C0014I2 (fr) 2022-03-11
PL395509A1 (pl) 2011-12-19
BE2011C008I2 (enExample) 2022-02-02
PL395510A1 (pl) 2011-12-19
EP1487483A4 (en) 2006-02-15
HU228584B1 (en) 2013-04-29
LT2264050T (lt) 2018-11-26
AU2008202333A1 (en) 2008-06-19
CY2011004I2 (el) 2015-10-07
PT2263689E (pt) 2015-02-13
AU2011200843B2 (en) 2012-01-19
AU2002362147C1 (en) 2012-05-17
EP2264050A3 (en) 2011-04-20
HRP20140002B1 (hr) 2020-10-16
PT2264050T (pt) 2018-11-21
EP2263690A2 (en) 2010-12-22
MEP17708A (bs) 2010-06-10
EP2263689A3 (en) 2011-04-20
TWI314580B (en) 2009-09-11
SI1487483T1 (sl) 2011-03-31
BRPI0214919B1 (pt) 2015-09-15
ATE487490T1 (de) 2010-11-15
CA2784260A1 (en) 2003-06-19
EP2263689B1 (en) 2014-11-12
FR11C0014I1 (enExample) 2011-06-17
EP3388515A1 (en) 2018-10-17
CA2469599C (en) 2012-10-23
HU231018B1 (hu) 2019-11-28
WO2003049703A2 (en) 2003-06-19
DK2263689T3 (en) 2015-02-02
EP2263689A2 (en) 2010-12-22
CA2469599A1 (en) 2003-06-19
HRP20140003A2 (hr) 2014-11-07
DK1487483T3 (da) 2011-02-21
CA2784260C (en) 2016-05-17
LU91814I2 (fr) 2011-07-04
CO5590938A2 (es) 2005-12-30
AU2011200843A1 (en) 2011-03-17
CN103536911B (zh) 2019-09-13
DK2264050T3 (en) 2018-12-03
HK1151988A1 (en) 2012-02-17
SI2263689T1 (sl) 2015-03-31
CN103536911A (zh) 2014-01-29
PL215058B1 (pl) 2013-10-31
KR101014544B1 (ko) 2011-02-16
DE60238278D1 (de) 2010-12-23
MXPA04005364A (es) 2004-09-27
HU231162B1 (hu) 2021-05-28
JP2005511075A (ja) 2005-04-28
ME00126B (me) 2010-10-10
CY1121112T1 (el) 2019-12-11
CN1620310B (zh) 2014-11-26
HRP20040626A2 (en) 2006-03-31
HRP20040626B9 (hr) 2016-09-23
WO2003049703A8 (en) 2005-12-01
ES2529726T3 (es) 2015-02-25
RS51704A (sr) 2006-10-27
EP1487483B1 (en) 2010-11-10
AU2008202333B2 (en) 2010-11-25
HRP20140003B1 (hr) 2020-10-16
CY2011004I1 (el) 2014-04-09
EP1487483A2 (en) 2004-12-22
BR0214919A (pt) 2006-05-30
HRP20040626B1 (hr) 2016-08-26
HUP1300097A2 (en) 2007-12-28
ES2694505T3 (es) 2018-12-21
PL374382A1 (en) 2005-10-17
AU2002362147B2 (en) 2008-03-13
US7276353B2 (en) 2007-10-02
CN1620310A (zh) 2005-05-25
PL214803B1 (pl) 2013-09-30
EP2264050B1 (en) 2018-08-08
TW200307042A (en) 2003-12-01
JP4623964B2 (ja) 2011-02-02
US20030170270A1 (en) 2003-09-11
CY1111167T1 (el) 2014-04-09
RS51288B (sr) 2010-12-31
HUP0501000A2 (en) 2007-12-28
NZ533256A (en) 2008-06-30
ES2355814T3 (es) 2011-03-31

Similar Documents

Publication Publication Date Title
HUS2100036I1 (hu) Kiméra fertõzõ DNS-klónok, kiméra sertés cirkovírusok, és alkalmazásuk
WO2005092069A3 (en) Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
HUP0102770A2 (hu) Sertésircovírus-antigént és sertésparvovírus-antigént tartalmazó vakcina
HUP0003756A2 (hu) Újonnan izolált, sertésből származó cirkovírusok, vakcinák és diagnosztikai reagensek
ZA202105975B (en) Variant aav capsids for intravitreal delivery
EP4219695A3 (en) Adeno-associated virus variant capsids and use for inhibiting angiogenesis
WO1999029717A3 (en) Postweaning multisystemic wasting syndrome virus from pigs
AP2002002685A0 (en) Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
AU2007353480B2 (en) Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
AU4195696A (en) Hepatitis e virus antigens and uses therefor
WO2024163979A3 (en) Engineered aav polypeptides
CY1116098T1 (el) Χιμαιρικοι μολυσματικοι κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων